Gastrointestinal Endoscopy Devices | Market Insights | Asia Pacific | 2024
The Asia Pacific GI endoscopy device market was negatively impacted by the COVID-19 pandemic. Following recovery, the market will grow moderately throughout the forecast period, mainly due to the efficiency of nationwide CRC and GI cancer screening programs, especially in Australia and South Korea, the high incidence of gastric cancer and CRC cases in the region, the increasing uptake of GI endoscopy devices among physicians due to training programs and conferences, and the improving healthcare infrastructure, especially in China and India. However, ASP declines due to price-based competition will continue to hamper some segments within the Asia Pacific GI endoscopy devices market.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Asia Pacific from 2019 through 2032.